Following the Concentration of Polymeric Nanoparticles During Nebulization

被引:35
作者
Beck-Broichsitter, Moritz [1 ]
Knuedeler, Marie-Christine [1 ]
Schmehl, Thomas [1 ]
Seeger, Werner [1 ]
机构
[1] Univ Giessen, Dept Internal Med, Med Clin 2, D-35392 Giessen, Germany
关键词
aggregation; biodegradable nanoparticles; concentration changes; pulmonary drug delivery; vibrating-membrane nebulization; BIODEGRADABLE NANOPARTICLES; DRUG-DELIVERY; NANOTECHNOLOGY; PERFORMANCE; FORMULATION; DESIGN; IMPACT; NANO; JET;
D O I
10.1007/s11095-012-0819-0
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Nebulization represents one strategy to achieve pulmonary deposition of biodegradable nanoparticles. Besides stability as a key requirement to maintain functionality, the output of nanoparticles from the nebulizer needs to be considered to facilitate an efficient pulmonary therapy. Formulations nebulized by air-jet and vibrating-membrane technology were analyzed for their aerodynamic characteristics by laser diffraction. The nebulization stability of poly(D,L-lactide-co-glycolide) nanoparticles was assessed by dynamic light scattering. Moreover, several methods were employed to account for the shift in solute and NP reservoir concentration during nebulization. Regardless of the formulation or nebulizer used generated aerosols all showed aerodynamic characteristics suitable for deep lung deposition. However, nanoparticles were prone to aggregation and concentrated during air-jet nebulization. The particle concentration effect was significantly pronounced in comparison to molecular solutes under the same nebulization conditions, due to nanoparticle aggregation and subsequent particle remainder in the reservoir. In contrast, vibrating-membrane technology did not affect nanoparticle integrity and reservoir concentration during nebulization, as the unaffected submicron particles passed through the tapered holes of the actuated plate. Aggregation and concentration effects during air-jet nebulization emphasize that nanosuspensions should preferably be delivered with a suitable vibrating-membrane device in order to ensure an effective pulmonary application.
引用
收藏
页码:16 / 24
页数:9
相关论文
共 36 条
  • [21] Lass Joseph S, 2006, Expert Opin Drug Deliv, V3, P693, DOI 10.1517/17425247.3.5.693
  • [22] Moving smaller in drug discovery and delivery
    LaVan, DA
    Lynn, DM
    Langer, R
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2002, 1 (01) : 77 - 84
  • [23] Surfactant-free redispersible nanoparticles in fast-dissolving composite microcarriers for dry-powder inhalation
    Lebhardt, Tobias
    Roesler, Susanne
    Uusitalo, Henna P.
    Kissel, Thomas
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2011, 78 (01) : 90 - 96
  • [24] Nebulisation of monodisperse latex sphere suspensions in air-jet and ultrasonic nebulisers
    McCallion, ONM
    Taylor, KMG
    Thomas, M
    Taylor, AJ
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1996, 133 (1-2) : 203 - 214
  • [25] Laser diffractometry as a technique for the rapid assessment of aerosol particle size from inhalers
    Mitchell, Jolyon P.
    Nagel, Mark W.
    Nichols, Steve
    Nerbrink, Ola
    [J]. JOURNAL OF AEROSOL MEDICINE-DEPOSITION CLEARANCE AND EFFECTS IN THE LUNG, 2006, 19 (04): : 409 - 433
  • [26] Pulmonary Gene Silencing in Transgenic EGFP Mice Using Aerosolised Chitosan/siRNA Nanoparticles
    Nielsen, Ebbe J. B.
    Nielsen, Jan M.
    Becker, Daniel
    Karlas, Alexander
    Prakash, Hridayesh
    Glud, Sys Z.
    Merrison, Jonathan
    Besenbacher, Flemming
    Meyer, Thomas F.
    Kjems, Jorgen
    Howard, Kenneth A.
    [J]. PHARMACEUTICAL RESEARCH, 2010, 27 (12) : 2520 - 2527
  • [27] Inhaled iloprost for severe pulmonary hypertension
    Olschewski, H
    Simonneau, G
    Galiè, N
    Higenbottam, T
    Naeije, R
    Rubin, LJ
    Nikkho, S
    Speich, R
    Hoeper, MM
    Behr, J
    Winkler, J
    Sitbon, O
    Popov, W
    Ghofrani, HA
    Manes, A
    Kiely, DG
    Ewert, R
    Siedentop, H
    Seeger, W
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (05) : 322 - 329
  • [28] Stabilization of Aerosolizable Nano-carriers by Freeze-Drying
    Packhaeuser, Claudia B.
    Lahnstein, Kerstin
    Sitterberg, Johannes
    Schmehl, Thomas
    Gessler, Tobias
    Bakowsky, Udo
    Seeger, Werner
    Kissel, Thomas
    [J]. PHARMACEUTICAL RESEARCH, 2009, 26 (01) : 129 - 138
  • [29] Inhaling medicines: delivering drugs to the body through the lungs
    Patton, John S.
    Byron, Peter R.
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2007, 6 (01) : 67 - 74
  • [30] In vitro and in vivo performance of biocompatible negatively-charged salbutamol-loaded nanoparticles
    Rytting, Erik
    Bur, Michael
    Cartier, Regis
    Bouyssou, Thierry
    Wang, Xiaoying
    Krueger, Michael
    Lehr, Claus-Michael
    Kissel, Thomas
    [J]. JOURNAL OF CONTROLLED RELEASE, 2010, 141 (01) : 101 - 107